Jim O'Neill Chosen as Deputy HHS Secretary

President-elect Donald Trump has announced Jim O'Neill as his choice for Deputy Secretary of Health and Human Services (HHS), working alongside Robert F. Kennedy Jr. O'Neill, an investor with strong ties to Peter Thiel, previously served as Principal Associate Deputy Secretary of HHS during the George W. Bush administration, and his nomination has drawn both interest and concern due to his unconventional views on drug approval processes. O'Neill advocates for the FDA to approve drugs based solely on safety, with efficacy to be proven post-legalization, a stance that has raised eyebrows among health experts. His selection is part of a broader array of appointments, including Johns Hopkins surgeon Marty Makary to lead the FDA, highlighting Trump's focus on individuals with non-traditional perspectives in health leadership roles. The choice of O'Neill has sparked discussions about his ability to work effectively within a team that has expressed skepticism towards mainstream health approaches.